Abbott Labs (GB:0Q15)

Abbott Labs (0Q15) Share Price & Analysis


0Q15 Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$92.48 - $115.95
Previous Close$103.85
Average Volume (3M)46.44K
Market Cap
Enterprise Value$188.79B
Total Cash (Recent Filing)$9.53B
Total Debt (Recent Filing)$16.90B
Price to Earnings (P/E)31.6
Jul 19, 2023
1.96 (1.88%)
Share Statistics
EPS (TTM)3.29
Shares Outstanding1,738,946,799
10 Day Avg. Volume69
30 Day Avg. Volume46,437
Standard Deviation0.04
Financial Highlights & Ratios
Price to Book (P/B)43.23
Price to Sales (P/S)10.17
Price to Cash Flow (P/CF)38.80
P/FCF Ratio34.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.55
Enterprise Value/Gross Profit7.70
Enterprise Value/Ebitda18.14
Price Target Upside17.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14



0Q15 FAQ

What was Abbott Labs’s price range in the past 12 months?
Abbott Labs lowest share price was $92.48 and its highest was $115.95 in the past 12 months.
    What is Abbott Labs’s market cap?
    Currently, no data Available
    When is Abbott Labs’s upcoming earnings report date?
    Abbott Labs’s upcoming earnings report date is Jul 19, 2023 which is in 43 days.
      How were Abbott Labs’s earnings last quarter?
      Abbott Labs released its earnings results on Apr 19, 2023. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.99 by $0.04.
        Is Abbott Labs overvalued?
        According to Wall Street analysts Abbott Labs’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Abbott Labs pay dividends?
          Abbott Labs pays a Quarterly dividend of $0.51 which represents an annual dividend yield of 1.88%. See more information on Abbott Labs dividends here
            What is Abbott Labs’s EPS estimate?
            Abbott Labs’s EPS estimate is $1.05.
              How many shares outstanding does Abbott Labs have?
              Abbott Labs has 1,738,946,800 shares outstanding.
                What happened to Abbott Labs’s price movement after its last earnings report?
                Abbott Labs reported an EPS of $1.03 in its last earnings report, beating expectations of $0.99. Following the earnings report the stock price went up 7.389%.
                  Which hedge fund is a major shareholder of Abbott Labs?
                  Among the largest hedge funds holding Abbott Labs’s share is Fisher Asset Management LLC. It holds Abbott Labs’s shares valued at 959M.


                    Abbott Labs Stock Smart Score

                    The Abbott Labs Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Abbott Labs

                    Abbott Laboratories offers a diversified line of healthcare products. It operates through four reportable segments: Established Pharmaceutical Products International (includes international sales of branded generic pharmaceutical products), Nutritional Products Diagnostic Products and Medical Devices. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Abbott Labs
                    Baxter International
                    Boston Scientific

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis